DOCSLIB.ORG
  • Sign Up
  • Log In
  • Upload
  • Sign Up
  • Log In
  • Upload
  • Home
  • »  Tags
  • »  Bicalutamide

Bicalutamide

  • CASODEX (Bicalutamide)

    CASODEX (Bicalutamide)

  • COVID-19—The Potential Beneficial Therapeutic Effects of Spironolactone During SARS-Cov-2 Infection

    COVID-19—The Potential Beneficial Therapeutic Effects of Spironolactone During SARS-Cov-2 Infection

  • Hormonal Treatment Strategies Tailored to Non-Binary Transgender Individuals

    Hormonal Treatment Strategies Tailored to Non-Binary Transgender Individuals

  • Epigenetic Therapy with Panobinostat Combined with Bicalutamide Rechallenge in Castration- Resistant Prostate Cancer Anna C

    Epigenetic Therapy with Panobinostat Combined with Bicalutamide Rechallenge in Castration- Resistant Prostate Cancer Anna C

  • Feminizing Hormone Therapy

    Feminizing Hormone Therapy

  • Minutes of PRAC Meeting on 09-12 July 2018

    Minutes of PRAC Meeting on 09-12 July 2018

  • Solubility of Bicalutamide, Megestrol Acetate, Prednisolone

    Solubility of Bicalutamide, Megestrol Acetate, Prednisolone

  • Long Term Hormone Treatment

    Long Term Hormone Treatment

  • Aetna Formulary Exclusions Drug List

    Aetna Formulary Exclusions Drug List

  • The Role of Highly Selective Androgen Receptor (AR) Targeted

    The Role of Highly Selective Androgen Receptor (AR) Targeted

  • Feminizing Gender-Affirming Hormone Care the Michigan Medicine Approach

    Feminizing Gender-Affirming Hormone Care the Michigan Medicine Approach

  • OUH Formulary Approved for Use in Breast Surgery

    OUH Formulary Approved for Use in Breast Surgery

  • E-Table 1. Drug Classification Category Name Generic Name

    E-Table 1. Drug Classification Category Name Generic Name

  • Product Monograph Casodex®

    Product Monograph Casodex®

  • Study Protocol and Statistical Analysis Plan

    Study Protocol and Statistical Analysis Plan

  • Managing the Complications of Hormonal Therapy (Males) QP-1 Oncologysdhnhsft/01.12/Review/01.14

    Managing the Complications of Hormonal Therapy (Males) QP-1 Oncologysdhnhsft/01.12/Review/01.14

  • Final Research Report

    Final Research Report

  • List of Formulary Drug Removals

    List of Formulary Drug Removals

Top View
  • Drugs Contraindicated in Pregnancy
  • Oncological Outcomes of Hormonal Therapy with a Gonadotropin
  • Investigation of Biopharmaceutical and Physicochemical Drug
  • Drugs/Medications Known to Cause Hyperhidrosis Certain Prescriptions
  • 2012 NIOSH List of Antineoplastic and Other Hazardous Drugs
  • 1 SUPPLEMENTAL MATERIALS Supplemental Table 1
  • Hot Flashes During Combined Androgen Blockade Therapy
  • BICALUTAMIDE -- Withdrawn Due to Accelerated Deaths
  • 22310S000 Bicalutamide Clinical Pediatric Review
  • Perioperative Medication Management - Adult/Pediatric - Inpatient/Ambulatory Clinical Practice Guideline
  • Bicalutamide
  • Hair-Loss-Handouts-180916
  • Prevention and Management of Bicalutamide-Induced Gynecomastia and Breast Pain: Randomized Endocrinologic and Clinical Studies with Tamoxifen and Anastrozole
  • Bicalutamide Patient Handout
  • And Bicalutamide-Resistant Prostate Cancer Chengfei Liu1, Cameron M
  • Synthesis and Biological Evaluation of Bicalutamide Analogues for the Potential Treatment of Prostate Cancer
  • WHO Model List of Essential Medicines
  • Initial Flare Symptoms Resulting from Use of LHRH Agonist in Metastatic Prostate Cancer: Systematic Review and Economic Evaluation


© 2024 Docslib.org    Feedback